NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

tandemdiabetes.com ↗
—
Latest disclosed NPS
no score published
4
NPS entries
0 with a number
70%
Retention
27 Feb 2025
2018–25
Years covered
9 entries in all

In their words

“Renewals continue to meet historically high retention rates on pace for consistent achievement of 70% capture within 18 months of warranty expiration.”
— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q4 2024 · 27 Feb 2025
“We are on track to reach a cumulative renewal rate of approximately 60% by the end of 2021, compared to 50% at the end of last year.”
— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q2 2021 · 4 Aug 2021
“We have increased our cumulative renewal rates at 55%, which is up 5 percentage points from the end of 2019 reinforcing the ability to reach our longer term goal of a 70% renewal rate.”
— Leigh Vosseller, Chief Financial Officer (CFO), Tandem Diabetes Care, Inc. · Earnings call, Q4 2020 · 24 Feb 2021

NPS disclosures (4)

Search the database →

27 Feb 2025
NPSProgram

In dQ&A, Tandem had the highest Net Promoter Score, outperforming all other competitors. This reflects our deep dedication and commitment to delivering a best-in-class customer experience.

— Mark Novara, Chief Commercial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q4 2024 · 27 Feb 2025
Earnings call, Q4 2024 ↗
24 Feb 2021
NPSProgram

Our keystone next to satisfaction score in the survey exceeded 90%, which we - and we continued to have high net promoter scores. That's more typical of leading consumer brands than medtech.

— John Sheridan, Chief Executive Officer (CEO), Tandem Diabetes Care, Inc. · Earnings call, Q4 2020 · 24 Feb 2021
Earnings call, Q4 2020 ↗
5 Nov 2020
NPSProgram

Our NPS scores which already aligned with the high level seen in consumer technology, increased by an impressive 12 points over 2019. In addition, we continue to achieve great success, both in capturing market share and expanding the insulin pump…

— John Sheridan, Chief Executive Officer, Tandem Diabetes Care, Inc. · Earnings call, Q3 2020 · 5 Nov 2020
Earnings call, Q3 2020 ↗
2 Aug 2019
NPSProgram

And finally both surveys showed that we have a world-class net promoter score, and dQ&A highlighted the Tandem is the highest among pump manufacturers.

— Brian Hansen, Senior Vice President, International, Tandem Diabetes Care, Inc. · Earnings call, Q2 2019 · 2 Aug 2019
Earnings call, Q2 2019 ↗

Retention disclosures (5)

Open in the retention database →

27 Feb 2025
Retention70%

Retention rate: 70% (Q4 2024) — “Renewals continue to meet historically high retention rates on pace for consistent achievement of 70% capture within 18 months of warranty expiration.”

— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q4 2024 · 27 Feb 2025
Earnings call, Q4 2024 ↗
4 Aug 2021
Retention60%

Retention rate: 60% (end of 2021) — “We are on track to reach a cumulative renewal rate of approximately 60% by the end of 2021, compared to 50% at the end of last year.”

— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q2 2021 · 4 Aug 2021
Earnings call, Q2 2021 ↗
24 Feb 2021
Retention55%

Retention rate: 55% (Q4 2020) — “we have increased our cumulative renewal rates at 55%, which is up 5 percentage points from the end of 2019 reinforcing the ability to reach our longer term goal of a 70% renewal rate.”

— Leigh Vosseller, Chief Financial Officer (CFO), Tandem Diabetes Care, Inc. · Earnings call, Q4 2020 · 24 Feb 2021
Earnings call, Q4 2020 ↗
1 Mar 2018
Retention70%

Retention rate: 70% — “Our ultimate goal is to retain at least 70% of our existing customers”

— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q4 2017 · 1 Mar 2018
Earnings call, Q4 2017 ↗
1 Mar 2018
Retention30%

Retention rate: 30% (2017) — “we shipped about 2,000 renewals in the 2017 which represents if you look back to 2013 about a 30% rate”

— Leigh Vosseller, Chief Financial Officer, Tandem Diabetes Care, Inc. · Earnings call, Q4 2017 · 1 Mar 2018
Earnings call, Q4 2017 ↗

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.